DEGRADO WILLIAM F has a total of 19 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are CELLIX BIO PRIVATE LTD, HAMMOCK BRUCE D and KOYA KEIZO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers | |
#4 | Computer technology | |
#5 | Biotechnology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Degrado William F | 19 |
#2 | Liu Dahui | 8 |
#3 | Tew Gregory N | 8 |
#4 | Klein Michael L | 7 |
#5 | Wang Jun | 5 |
#6 | Choi Sungwook | 5 |
#7 | Yuan Jing | 3 |
#8 | Bennett Joel S | 2 |
#9 | Scott Richard W | 2 |
#10 | Tang Haizhong | 2 |
Publication | Filing date | Title |
---|---|---|
US2012028957A1 | Inhibitors of the influenza A virus M2 proton channel | |
US2012270917A1 | Adamantane analogs | |
US2010105703A1 | Synthetic mimetics of host defense and uses thereof | |
US2010179119A1 | Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold | |
US2011288111A1 | Inhibition of influenza M2 proton channel | |
US2011236881A1 | Modulation of influenza virus | |
WO2004065363A2 | Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel kcsa |